NCT05220371

Brief Summary

The present study aims at investigating the potential influence of specific collagen peptides on recovery after exercise induced muscle damage with focus on long-term effects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 28, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

January 28, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 2, 2022

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
Last Updated

August 28, 2023

Status Verified

August 1, 2023

Enrollment Period

1.4 years

First QC Date

January 28, 2022

Last Update Submit

August 23, 2023

Conditions

Keywords

Collagen peptidesConcurrent trainingUltrasoundMVCRFD

Outcome Measures

Primary Outcomes (10)

  • Change in maximal voluntary contraction (MVC)

    Measured by isokinetic dynamometer

    Baseline (pre, post, 24 hours, 48 hours) and after 12 weeks (pre, post, 24 hours, 48 hours)

  • Change in rate of force development (RFD)

    Measured by isokinetic dynamometer

    Baseline (pre, post, 24 hours, 48 hours) and after 12 weeks (pre, post, 24 hours, 48 hours)

  • Change in countermovement jump height (CMJ)

    Measured by force plate

    Baseline (pre, post, 24 hours, 48 hours) and after 12 weeks (pre, post, 24 hours, 48 hours)

  • Change in subjective pain score

    Measured by visual analogue scale

    Baseline (pre, post, 24 hours, 48 hours) and after 12 weeks (pre, post, 24 hours, 48 hours)

  • Change in Achilles tendon cross-sectional area

    Measured by ultrasound

    Baseline and after 12 weeks

  • Change in Vastus Lateralis fibre length

    Measured by ultrasound

    Baseline (pre, post, 24 hours, 48 hours) and after 12 weeks (pre, post, 24 hours, 48 hours)

  • Change in collagen related blood markers

    Measured by blood analysis

    Baseline (pre, post, 2 hours, 24 hours, 48 hours) and after 12 weeks (pre, post, 2 hours, 24 hours, 48 hours)

  • Change in Achilles tendon echo intensity

    Measured by ultrasound

    Baseline and after 12 weeks

  • Change in Vastus Lateralis echo intensity

    Measured by ultrasound

    Baseline and after 12 weeks

  • Change in body composition parameters (fat mass, fat-free mass, extracellular mass, body cell mass)

    Measured by bioelectrical impedance analysis

    Baseline and after 12 weeks

Study Arms (2)

Collagen

EXPERIMENTAL

15g of collagen peptides ingested daily

Dietary Supplement: CollagenOther: Concurrent training

Placebo

PLACEBO COMPARATOR

15g of Placebo ingested daily

Other: Concurrent training

Interventions

CollagenDIETARY_SUPPLEMENT

Participants ingest 15 grams of either specific collagen peptides or Placebo daily

Collagen

Both arms undergo a 12-week trainingintervention 3x/week

CollagenPlacebo

Eligibility Criteria

Age18 Years - 40 Years
Sexmale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • No subjective symptoms during physical exertion
  • Stable weight and dietary behaviour
  • Body Mass Index (BMI) between 18.5 and 24.9
  • No extensive strength/endurance sports so far (less than 3 h/week)
  • No complaints during strenuous physical activity

You may not qualify if:

  • Circumstances that impair/prevent sporting activity (e.g. chronic heart disease, arrhythmia, heart valve disease, arthritis etc.)
  • Intolerance/aversion to animal protein
  • Arterial hypertension (high blood pressure) (syst \> 200 mmHg and/or diast \> 105 mmHg) at rest
  • Presence of insulin-dependent diabetes mellitus
  • Liver and/or kidney disease that precludes a high protein load
  • Collagen supplementation or regular intake of other dietary supplements in the last 6 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Vienna, Institute of Sport Science

Vienna, 1150, Austria

Location

Related Publications (2)

  • Bischof K, Stafilidis S, Bundschuh L, Oesser S, Baca A, Konig D. Reduction in systemic muscle stress markers after exercise-induced muscle damage following concurrent training and supplementation with specific collagen peptides - a randomized controlled trial. Front Nutr. 2024 Mar 25;11:1384112. doi: 10.3389/fnut.2024.1384112. eCollection 2024.

  • Bischof K, Stafilidis S, Bundschuh L, Oesser S, Baca A, Konig D. Influence of specific collagen peptides and 12-week concurrent training on recovery-related biomechanical characteristics following exercise-induced muscle damage-A randomized controlled trial. Front Nutr. 2023 Nov 16;10:1266056. doi: 10.3389/fnut.2023.1266056. eCollection 2023.

MeSH Terms

Interventions

Collagen

Intervention Hierarchy (Ancestors)

BiopolymersPolymersMacromolecular SubstancesExtracellular Matrix ProteinsScleroproteinsProteinsAmino Acids, Peptides, and Proteins

Study Officials

  • Daniel Koenig, Prof. Dr.

    University of Vienna, Institute of Sport Science

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Double-blind, randomized controlled trial
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Univ.-Prof. Dr. med. Daniel König

Study Record Dates

First Submitted

January 28, 2022

First Posted

February 2, 2022

Study Start

January 28, 2022

Primary Completion

June 30, 2023

Study Completion

June 30, 2023

Last Updated

August 28, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations